Used in pharmaceutical research as a key intermediate in the synthesis of nicotinic acetylcholine receptor (nAChR) ligands. It plays a role in developing compounds targeting neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Its structure supports high affinity binding to specific nAChR subtypes, making it valuable in the design of cognitive enhancers and anti-addiction therapies. Also explored in the development of novel antidepressants and anxiolytics due to its influence on cholinergic neurotransmission.